The Power of Malaria Vaccine Trials Using Controlled Human Malaria Infection
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Power of Malaria Vaccine Trials Using Controlled Human Malaria Infection
Authors
Keywords
Vaccines, Blood, Parasitic diseases, Malarial parasites, Malaria, Parasite replication, Infectious disease control, Statistical models
Journal
PLoS Computational Biology
Volume 13, Issue 1, Pages e1005255
Publisher
Public Library of Science (PLoS)
Online
2017-01-13
DOI
10.1371/journal.pcbi.1005255
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Design, recruitment, and microbiological considerations in human challenge studies
- (2015) Thomas C Darton et al. LANCET INFECTIOUS DISEASES
- Memory B-Cell and Antibody Responses Induced by Plasmodium falciparum Sporozoite Immunization
- (2014) Wiebke Nahrendorf et al. JOURNAL OF INFECTIOUS DISEASES
- Sequential Phase 1 and Phase 2 randomized, controlled trials of the safety, immunogenicity and efficacy of combined pre-erythrocytic vaccine antigens RTS,S and TRAP formulated with AS02 Adjuvant System in healthy, malaria naïve adults
- (2014) Kent E. Kester et al. VACCINE
- Comparison of Modeling Methods to Determine Liver-to-blood Inocula and Parasite Multiplication Rates During Controlled Human Malaria Infection
- (2013) Alexander D. Douglas et al. JOURNAL OF INFECTIOUS DISEASES
- Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data
- (2013) Philip Bejon et al. LANCET INFECTIOUS DISEASES
- Optimising Controlled Human Malaria Infection Studies Using Cryopreserved P. falciparum Parasites Administered by Needle and Syringe
- (2013) Susanne H. Sheehy et al. PLoS One
- Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunity
- (2013) E. M. Bijker et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Controlled Human Malaria Infections by Intradermal Injection of Cryopreserved Plasmodium falciparum Sporozoites
- (2012) Meta Roestenberg et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Efficacy of Preerythrocytic and Blood-Stage Malaria Vaccines Can Be Assessed in Small Sporozoite Challenge Trials in Human Volunteers
- (2012) M. Roestenberg et al. JOURNAL OF INFECTIOUS DISEASES
- NF135.C10: A New Plasmodium falciparum Clone for Controlled Human Malaria Infections
- (2012) Anne C. Teirlinck et al. JOURNAL OF INFECTIOUS DISEASES
- A review of malaria vaccine clinical projects based on the WHO rainbow table
- (2012) Lauren Schwartz et al. MALARIA JOURNAL
- ChAd63-MVA–vectored Blood-stage Malaria Vaccines Targeting MSP1 and AMA1: Assessment of Efficacy Against Mosquito Bite Challenge in Humans
- (2012) Susanne H Sheehy et al. MOLECULAR THERAPY
- Comparison of Clinical and Parasitological Data from Controlled Human Malaria Infection Trials
- (2012) Meta Roestenberg et al. PLoS One
- Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study
- (2011) Meta Roestenberg et al. LANCET
- Randomized, Double‐Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria‐Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection
- (2009) Kent E. Kester et al. JOURNAL OF INFECTIOUS DISEASES
- Protection against a Malaria Challenge by Sporozoite Inoculation
- (2009) Meta Roestenberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Plasmodium falciparum var gene transcription strategy at the onset of blood stage infection in a human volunteer
- (2009) Christian W. Wang et al. PARASITOLOGY INTERNATIONAL
- Phase 1/2a Study of the Malaria Vaccine Candidate Apical Membrane Antigen-1 (AMA-1) Administered in Adjuvant System AS01B or AS02A
- (2009) Michele D. Spring et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started